Locked content Three foreign companies in bid for PŻB

Three companies, DFDS from Denmark, Fahrdienste TT-Line from Germany and Finnish Finnlines Oyj were accepted for the next stage of privatization process of Polish ferry operator Polska Żegluga Bałtycka (PŻB), the Ministry of State Treasury informed on its web page. State-owned PŻB was set up in 1976...

Locked content Medicover plans further expansion

A healthcare company, Medicover Polska, is planning large investments and an introduction of new brands this year. “In the next few years we want to open 10 healthcare facilities per year under three brands – Medicover, Centrum Damiana and Medi Partner,” said Sylwia Pyśkiewicz, deputy CEO of Medicov...

Locked content CDP.PL transformed into e-commerce marketplace

Warsaw based video game distributor, CDP.pl, is challenging Polish e-commerce leaders by broadening their online offer. The company is starting to sell books, movies, music albums and board games, in addition to video games. “We are starting our new e-store, which is aimed at competing with Merlin.p...

Locked content French Total enters Polish market

French oil and gas company, Total S.A, plans to set up a chain of gas stations in Poland. Although the company currently owns two filling stations in the country, it aims to initiate a large-scale expansion. “Our first target is 100 petrol stations in the next 2 years,” Thibaud de Lisle, the CEO of ...

Orlen posts PLN 1.22 billion net loss in Q4

Polish refiner, PKN Orlen’s, net loss amounts to PLN 1.22 billion in Q4, an increase from PLN 421 million one year earlier, the company said Friday. The loss is due to falling oil prices and one-off items.

Locked content PGNiG reduces costs and plans acquisitions

State controlled PGNiG announced it will cut administrative costs by PLN 1 billion by 2016, as part of a new strategy. “Since December we are working on our ‘zero initiative’ under which we are examining expenditures. The results of the audit will influence general management costs,” Mariusz Zawisza...

Locked content Sołowow invests in biotechnology

Polish tycoon Michał Sołowow invested PLN 12 million in OncoArendi Therapeutics, a company specializing in developing innovative anti-inflammatory and anti-cancer drugs. The sum is to cover R&D work in the next 3 years. “In my opinion, OncoArendi has an exceptional team of outstanding researcher...